Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

K. Vincent Speeg

Contact

210-567-5771

speeg@uthscsa.edu

Departments & Divisions

Institutes & Centers

Research

Research profile

Clinical

Provider profile

Kermit V Speeg, M.D.

Professor of Medicine

Transplant Hepatologist

Kermit V Speeg PhD (Rice University), MD (UT Southwestern Medical School). Gastroenterology at Vanderbilt University. Presently, Medical Director of Adult Liver Transplant at UT Health-San Antonio and UHS. Practice primarily focuses on acute and chronic liver disease patients and the care of post-transplant patients from either deceased donor or living donors.

  • Professional Background

    Education

    • 1977 - Clinical Fellowship - Gastroenterology - Vanderbilt University Medical School
    • 1974 - Residency - Medicine - Vanderbilt University Medical School
    • 1973 - Internship - Medicine - Vanderbilt University Medical School
    • 1972 - MD - Medicine - University of Texas Southwestern Medical School at Dallas
    • 1968 - PhD - Biology - Rice University
    • 1966 - MA - Biology - Rice University
    • 1965 - BA - Biology - Rice University

    Appointments

    • 8/1996 - Associate Medical Director - University Health SystemSan Antonio
    • 1/1993 - Medical Director - UT Health Science Center, Medicine, San Antonio
    • 6/1988 - Professor and Faculty Physician - UT Health Science Center, Medicine, San Antonio
    • 6/1988 - Staff Physician - University Health System, Medicine, San Antonio

  • Instruction & Training

    • 7/2005 - Present, Post-Doctoral Student Supervision, UTHSCSA
    • 7/2005 - Present, Post-Doctoral Student Supervision, UTHSCSA

  • Research & Grants

     

    Project #: 118375

    Funding Agency: IDUN Pharmaceuticals

    Title: Safety, tolerability and efficacy study of a caspase inhibitor, IND-6556 in patients undergoing orthotopic liver transplantation

    Status: Complete

    Period: 12/2003 - 01/2005

    Role: Co-Investigator

    % Effort:

    Total Costs: $170,000.00

    Grant Detail: Second lead enrolling site; publication in process

    Research profile

    Grants

    Private

    Funding Agency Roche Title Mycophenolate mofetil in treatment of hepatitis C virus infection Status Complete Period 6/2002 - 1/2029 Role Co-Investigator Grant Detail

  • Publications

      Book Chapter

      1.Espinoza A, Speeg KV, Washburn K, Halff G. Liver Transplantation In: Espinoza A, Speeg, Washburn K, Halff G. Essential Emergency Medicine for the Healthcare Practitioner. Saunders-Elsevier; 2007.

      2. Speeg KV, Halff GA, Schenker S. Metabolism of drugs before and after liver transplantation. In: Maddrey WC, Schiff E, Sorrell MF. Transplantation of the Liver, 3rd Ed. Philadelphia: Lippincott Williams & Wilkins; 2001.

      Journal Article

      Lee SM, Speeg KV, Pollack MS, Sharkey FA. Progression of morphologic changes after transplantation of a liver with heterozyzous alpha-1 antitrypsin deficiency Human Pathology 2012;43:753-756.

      2. Sharkey FE, Lytvak I, Prihoda TJ, Speeg KV, Washburn WK, Halff GA.. High-grade Microsteatosis and Delay in Hepatic Function after Orthotopic Liver Transplantation Human Pathology 2011:1337-1342.

  • Clinical

    Provider profile

    Board Certifications

    • 1976 - American Board of Internal Medicine
    • 1973 - National Board of Medical Examiners